- Home
- ASNS vs AEON Comparison
ASNS vs AEON Comparison
Compare ASNS & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASNS
- AEON
- Stock Information
- Founded
- ASNS 1998
- AEON N/A
- Country
- ASNS United States
- AEON United States
- Employees
- ASNS N/A
- AEON N/A
- Industry
- ASNS Telecommunications Equipment
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- ASNS Telecommunications
- AEON Health Care
- Exchange
- ASNS Nasdaq
- AEON Nasdaq
- Market Cap
- ASNS 6.1M
- AEON 5.7M
- IPO Year
- ASNS 2022
- AEON N/A
- Fundamental
- Price
- ASNS $0.71
- AEON $0.82
- Analyst Decision
- ASNS Strong Buy
- AEON Strong Buy
- Analyst Count
- ASNS 1
- AEON 1
- Target Price
- ASNS $5.00
- AEON $360.00
- AVG Volume (30 Days)
- ASNS 348.2K
- AEON 1.9M
- Earning Date
- ASNS 05-13-2025
- AEON 05-14-2025
- Dividend Yield
- ASNS N/A
- AEON N/A
- EPS Growth
- ASNS N/A
- AEON N/A
- EPS
- ASNS N/A
- AEON 73.23
- Revenue
- ASNS $7,755,000.00
- AEON N/A
- Revenue This Year
- ASNS N/A
- AEON N/A
- Revenue Next Year
- ASNS $104.77
- AEON N/A
- P/E Ratio
- ASNS N/A
- AEON $0.01
- Revenue Growth
- ASNS 72.95
- AEON N/A
- 52 Week Low
- ASNS $0.53
- AEON $0.38
- 52 Week High
- ASNS $2.73
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- ASNS 48.69
- AEON 67.31
- Support Level
- ASNS $0.66
- AEON $0.53
- Resistance Level
- ASNS $0.77
- AEON $0.85
- Average True Range (ATR)
- ASNS 0.06
- AEON 0.08
- MACD
- ASNS 0.00
- AEON 0.05
- Stochastic Oscillator
- ASNS 55.71
- AEON 92.78
About ASNS Actelis Networks Inc.
Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.